ACURX PHARMACEUTICALS INC (ACXP) Stock Income Statement
NASDAQ:ACXP - US00510M1045 - Common Stock
5.1 USD
-0.21 (-3.91%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 10.02M | 14.10M | 14.58M | 12.09M | 12.82M | |||
| Research and Development | 3.15M | 5.40M | 6.04M | 4.75M | 2.03M | |||
| Selling, General, and Administrative Expenses | 6.88M | 8.70M | 8.53M | 7.34M | 10.78M | |||
| Operating Income | -10.02M | -14.10M | -14.58M | -12.09M | -12.82M | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 70.00K | |||
| Income Before Taxes | -10.00M | -14.10M | -14.58M | -12.09M | -12.75M | |||
| Net Income | -10.00M | -14.10M | -14.58M | -12.09M | -12.75M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.76 | -17.45 | -23.01 | -22.35 | -29.87 | |||
| Non GAAP EPS | -4.42 | -0.87 | -1.14 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD